| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |